GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · IEX Real-Time Price · USD
1.830
+0.110 (6.40%)
At close: May 3, 2024, 4:00 PM
1.840
+0.010 (0.55%)
After-hours: May 3, 2024, 7:58 PM EDT

GlycoMimetics Revenue

In the year 2023, GlycoMimetics had annual revenue of $10.00K, a decrease of -86.67%. Revenue in the quarter ending December 31, 2023 was $10.00K.

Revenue (ttm)
$10.00K
Revenue Growth
-86.67%
P/S Ratio
11,794.42
Revenue / Employee
$286
Employees
35
Market Cap
117.94M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.00K-65.00K-86.67%
Dec 31, 202275.00K-1.08M-93.53%
Dec 31, 20211.16M-9.00M-88.59%
Dec 31, 202010.16M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 201618.50K-20.05M-99.91%
Dec 31, 201520.07M5.04M33.56%
Dec 31, 201415.03M11.03M276.37%
Dec 31, 20133.99M-11.26M-73.83%
Dec 31, 201215.26M11.44M300.04%
Dec 31, 20113.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 585.17M
Aurora Cannabis 200.73M
FibroGen 147.75M
Xtant Medical Holdings 91.30M
KORU Medical Systems 29.32M
Myomo 19.24M
Abeona Therapeutics 3.50M
aTyr Pharma 588.00K
Revenue Rankings